- Release Date: 12/04/23 09:08
- Summary: After FDA Review PXS Accelerates Plans for Combination Study
- Price Sensitive: Yes
- Download Document 223.25KB
- Forums
- ASX - By Stock
- SNT
- Ann: After FDA Review PXS Accelerates Plans for Combination Study
Ann: After FDA Review PXS Accelerates Plans for Combination Study
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SNT (ASX) to my watchlist
|
|||||
Last
3.4¢ |
Change
-0.001(2.86%) |
Mkt cap ! $45.16M |
Open | High | Low | Value | Volume |
3.6¢ | 3.6¢ | 3.4¢ | $44.46K | 1.261M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1283 | 3.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.5¢ | 93952 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1283 | 0.034 |
3 | 518181 | 0.033 |
4 | 1100384 | 0.032 |
4 | 1732580 | 0.031 |
6 | 1366666 | 0.030 |
Price($) | Vol. | No. |
---|---|---|
0.035 | 93952 | 3 |
0.036 | 1254608 | 4 |
0.037 | 134500 | 1 |
0.038 | 367592 | 2 |
0.039 | 348913 | 2 |
Last trade - 14.03pm 27/08/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online